To assess how Medicare price negotiation was associated with 30-day out-of-pocket costs for high-cost cardiovascular medications and whether generic availability affected the association.
Approach:
Design and data: Repeated cross-sectional, plan-level analysis of Medicare drug coverage data before and after negotiation implementation, using a difference-in-differences approach.
Medications and analysis: Compared medications selected for negotiation with nonselected cardiovascular medications. Separate models examined medications with and without newly available generic alternatives; confidence intervals used plan-level cluster bootstrapping.
Key Findings:
The analysis included 6,215 Medicare drug coverage plans: 5,738 Medicare Advantage and 477 stand-alone plans.
Negotiation was associated with a $56.63 decrease in 30-day out-of-pocket costs for medications without a generic option (95% CI, $55.48-$57.78).
For medications for which a generic became available, the associated decrease was $7.46 (95% CI, $6.05-$8.78).
Interpretation:
The authors reported that generic availability appeared to attenuate the association between price negotiation and lower out-of-pocket costs. They identified the timing of drug selection and negotiation as a potential missed opportunity.
Limitations:
The study covered only the first year of negotiation, a short period, and a small number of cardiovascular medications.
Costs reflected 30 days in the initial coverage phase and did not account for other contemporaneous policy changes.
Plan-level data did not include beneficiary enrollment, diagnoses, individual costs, other barriers, or clinical outcomes.
Conclusion:
The study found lower 30-day out-of-pocket costs associated with Medicare price negotiation, with a considerably smaller reduction for medications with newly available generic alternatives.
by Celeste W. Franklin, Nathalia Ladino, Neha Parvathala, Gary C. N. Hettinger, Harmony R. Reynolds, Samrachana Adhikari, Saul Blecker, Amrita Mukhopadhyay
Higher medical expenses increased financial anxiety and reduced willingness to schedule recommended procedures in 3 studies, with stronger effects among financially stressed participants.